Clinical trial
An Open-label Prospective Trial to Evaluate Functional Outcomes of OROS Methylphenidate in Children With ADHD (FOSCO)
NCT01012622 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Prospective Trial to Evaluate Functional Outcomes of OROS Methylphenidate in Children With ADHD (FOSCO)
- Lead sponsor
- Janssen Korea, Ltd., Korea
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- August 31, 2009
- Enrollment
- 142 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.